Neo Ivy Capital Management Integra Lifesciences Holdings Corp Transaction History

Neo Ivy Capital Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 29, 2023	BUY	$37.8 - $45.97 $12,096 - $14,710	320 New	320 $12,000
Q3 2022 Nov 15, 2022	BUY	$42.28 - $57.17 $30,272 - $40,933	716 New	716 $30,000
Q2 2022 Aug 16, 2022	SELL	$53.86 - $66.52 $200,359 - $247,454	-3,720 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$62.86 - $69.24 $233,839 - $257,572	3,720 New	3,720 $240,000
Q4 2021 Feb 15, 2022	SELL	$62.47 - $73.25 $355,391 - $416,719	-5,689 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$64.97 - $76.19 $369,614 - $433,444	5,689 New	5,689 $267,000
Q2 2020 Aug 17, 2020	SELL	$41.42 - $55.57 $235,638 - $316,137	-5,689 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$41.42 - $55.57 $146,088 - $195,995	3,527 Added 163.14%	5,689 $267,000
Q1 2020 May 15, 2020	BUY	$36.67 - $61.04 $79,280 - $131,968	2,162 New	2,162 $97,000

241

75.3M

585K

21.3K

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $1.85B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

Stay updated on Neo Ivy Capital Management with notifications on news.